IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |